 - Patients with clinically significant or uncontrolled hepatic, gastrointestinal, cardiovascular, respiratory, neurological including diabetic neuropathy, psychiatric, hematological, renal, dermatological disease, or any other medical condition that might interfere with the evaluation of the investigational medicinal product IMP according to Investigators medical judgment. 